Gilead to Buy Arcellx in $7.8 Billion Cancer Therapy Deal
The biotech giant announced it will acquire its partner Arcellx in a deal worth up to $7.8 billion. The acquisition…
The biotech giant announced it will acquire its partner Arcellx in a deal worth up to $7.8 billion. The acquisition…